Given its role in cancer metabolism, LDH has been investigated as a potential therapeutic target. Inhibitors of LDH could potentially disrupt the metabolic pathways that cancer cells rely on for growth and survival. Some experimental drugs and small molecules that inhibit LDH activity are currently being studied in preclinical and clinical trials.
